Despite a recently-agreed $7.4 billion settlement, the Sackler family has yet to fully account for its role in America's ...

But OxyContin is highly addictive and inasmuch ... misstated what prompted the Sackler family, owners of Purdue Pharma, to begin hiding money in offshore trusts and other asset-protection schemes ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for non-opioid pain treatments that could help quell the still raging opioid ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and other states said.

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...

The Sackler family and Purdue Pharma have agreed to ... The Sacklers, who brought OxyContin to the market through Purdue Pharma in the 1990s, have long been accused in the court of public opinion ...

Sackler family members agreed to pay the US Justice Department $225 million to settle civil claims while Purdue pleaded guilty to three federal felonies related to its marketing of OxyContin.

Representatives for Sackler family members did not immediately respond ... said she became addicted to opioids after receiving a prescription for OxyContin to deal with a back injury 23 years ...

Representatives for Sackler family members did not immediately respond to requests for comment. Kara Trainor, a Michigan woman in recovery for 17 years, said she became addicted to opioids after ...